Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Aggarwal

Showing results (151-160 of 223) with videos related to

Pageof 23
Sort By:
Nature Cell Biology|June 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progressionMeng Zhang, Martin Sjöström, Xiekui Cui, et al.
American Journal of Preventive Cardiology|July 3, 2026
Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohortNelson Wang, Deepak L Bhatt, Constance Xhaard, et al.
European Urology|March 6, 2017
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate CancerMatti Annala, Werner J Struss, Evan W Warner, et al.
Cancer Research|July 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor ProgressionRaunak Shrestha, Lisa N Chesner, Meng Zhang, et al.
Magnetic Resonance in Medicine|August 17, 2022
Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarized <sup>13</sup> C pyruvate metabolic imaging: A technical development studyHsin-Yu Chen, Robert A Bok, Matthew R Cooperberg, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
NMR in Biomedicine|September 20, 2018
Investigation of analysis methods for hyperpolarized 13C-pyruvate metabolic MRI in prostate cancer patientsPeder E Z Larson, Hsin-Yu Chen, Jeremy W Gordon, et al.
American Heart Journal|June 23, 2026
DOAC Score Among Patients Receiving Vitamin K AntagonistsRahul Aggarwal, Christian T Ruff, Michael G Palazzolo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter StudyStefano Fanti, Javier Jesus Robles Barba, Spencer Behr, et al.
Magnetic Resonance in Medicine|July 3, 2021
Specialized computational methods for denoising, B<sub>1</sub> correction, and kinetic modeling in hyperpolarized <sup>13</sup> C MR EPSI studies of liver tumorsPhilip M Lee, Hsin-Yu Chen, Jeremy W Gordon, et al.
Pageof 23

Showing results (151-160 of 223) with videos related to

Sort By:
Pageof 23
Nature Cell Biology|June 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progressionMeng Zhang, Martin Sjöström, Xiekui Cui, et al.
American Journal of Preventive Cardiology|July 3, 2026
Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohortNelson Wang, Deepak L Bhatt, Constance Xhaard, et al.
European Urology|March 6, 2017
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate CancerMatti Annala, Werner J Struss, Evan W Warner, et al.
Cancer Research|July 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor ProgressionRaunak Shrestha, Lisa N Chesner, Meng Zhang, et al.
Magnetic Resonance in Medicine|August 17, 2022
Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarized <sup>13</sup> C pyruvate metabolic imaging: A technical development studyHsin-Yu Chen, Robert A Bok, Matthew R Cooperberg, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
NMR in Biomedicine|September 20, 2018
Investigation of analysis methods for hyperpolarized 13C-pyruvate metabolic MRI in prostate cancer patientsPeder E Z Larson, Hsin-Yu Chen, Jeremy W Gordon, et al.
American Heart Journal|June 23, 2026
DOAC Score Among Patients Receiving Vitamin K AntagonistsRahul Aggarwal, Christian T Ruff, Michael G Palazzolo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter StudyStefano Fanti, Javier Jesus Robles Barba, Spencer Behr, et al.
Magnetic Resonance in Medicine|July 3, 2021
Specialized computational methods for denoising, B<sub>1</sub> correction, and kinetic modeling in hyperpolarized <sup>13</sup> C MR EPSI studies of liver tumorsPhilip M Lee, Hsin-Yu Chen, Jeremy W Gordon, et al.
Pageof 23